Ken, what I really meant by "new prescription" was that some here need to be honest about CytoDyn/LL pointing out (seeing) the good/bad as they view it, NOT limited to just the "rosey" aspects. Leronlimab APPEARS to be a ground-breaking molecule; however it remains to be seen whether current management can advance the ball across the goal to GENERATE REVENUES. To me, without practical application, the molecule is akin to a paperweight on one's desk. A chemical formula on a piece of paper, without practical application (monetization), is worthless.

I was, secondarily, trying to make a separate point that I think that there are many here that have WAY TOO MUCH of his/her net worth invested here, relative to other investments in his/her portfolio, and that "negative" thoughts are not welcome as they may adversely affect the pps. Some simply cannot afford to see the CYDY pps go down as they are "all-in." We now live in a "lottery ticket" world where so many want instant results (stock market, gym, entertainment talent, body, etc.), and have no patience or are willing to put in the effort for long-term results (investing in this case). Scared money can't win!